Question 1 · Hard
A 27-year-old man who moved to Abu Dhabi from South Asia 6 months ago has widespread, itchy, ring-shaped plaques on the groin, buttocks and trunk. They did not clear after 6 weeks of oral terbinafine 250 mg daily, and several family members have similar lesions. A KOH mount of skin scrapings shows septate hyphae. Culture on Sabouraud agar with cycloheximide at 28 °C grows, in 7 days, a white, powdery colony with many round microconidia in grape-like clusters, and the laboratory identifies it by morphology as Trichophyton mentagrophytes complex. What should the laboratory do next?
- ASequence the ITS region and test terbinafine susceptibility
- BDo a hair perforation test to exclude T. rubrum
- CRepeat the culture on dermatophyte test medium
- DReport T. mentagrophytes with no further testing
Show answerHide answer
Answer: A · Sequence the ITS region and test terbinafine susceptibility
Extensive, contagious tinea that fails terbinafine in a person from South Asia suggests Trichophyton indotineae, a member of the T. mentagrophytes complex that has spread from the Indian subcontinent to many countries. Its colonies and microscopy cannot be told apart from other members of the complex, so identification needs sequencing of the ITS region of ribosomal DNA. Most isolates carry mutations in the squalene epoxidase (SQLE) gene that cause terbinafine resistance, so antifungal susceptibility testing or SQLE sequencing is advised, often at a reference laboratory. Reporting 'T. mentagrophytes' alone would leave the cause of treatment failure undetected. The result also matters for public health, because the infection spreads within households.
- B: The morphology already excludes T. rubrum; the problem is terbinafine failure.
- C: DTM only shows that a dermatophyte is present and adds nothing here.
- D: This report would miss T. indotineae, which needs sequencing and susceptibility testing.